Venus Biosciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 5.10 M
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 40.00 Cr
- Satisfied Charges ₹ 136.77 Cr
- Revenue Growth 47.65%
- Profit Growth 37.85%
- Ebitda 43.41%
- Net Worth 22.25%
- Total Assets 39.58%
About Venus Biosciences
Company Details
-
Location
Solan, Himachal Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999HP2008PTC031161
-
Company No.
031161
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Jul 2008
-
Date of AGM
30 Sep 2016
-
Date of Balance Sheet
31 Mar 2016
-
Listing Status
Unlisted
-
ROC Code
Roc Himachal Pradesh
Industry
Who are the key members and board of directors at Venus Biosciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Kumar
|
Director | 19-May-2017 | Current |
|
Ramdeo Ram
|
Director | 01-Apr-2016 | Current |
Financial Performance of Venus Biosciences.
Venus Biosciences Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 47.65% increase. The company also saw a substantial improvement in profitability, with a 37.85% increase in profit. The company's net worth Soared by an impressive increase of 22.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Venus Biosciences?
In 2016, Venus Biosciences had a promoter holding of 56.67% and a public holding of 43.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Venus Pharmagenerics Private LimitedRamdeo Ram is a mutual person
-
Aleris Reality Private Limited
Ramdeo Ram is a mutual person
-
Concept Cartonz Private Limited
Ramdeo Ram is a mutual person
Charges (Loans)
₹40.00 Cr
₹136.77 Cr
Charges Breakdown by Lending Institutions
- Syndicate Bank : 40.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2015 | Syndicate Bank | ₹40.00 Cr | Open |
| 29 Mar 2014 | State Bank Of India | ₹69.25 Cr | Satisfied |
| 22 Jul 2011 | State Bank Of India | ₹28.75 Cr | Satisfied |
| 21 Dec 2009 | Allahabad Bank (Lead Banker) | ₹13.64 Cr | Satisfied |
| 13 Jul 2009 | Allahabad Bank (Lead Bank) | ₹17.64 Cr | Satisfied |
How Many Employees Work at Venus Biosciences?
Venus Biosciences has a workforce of 32 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Venus Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Venus Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
